WARSAW — Zimmer Biomet Holdings Inc., a global leader in musculoskeletal healthcare, is pleased to announce that the company has received 510(k) clearance from the U.S. Food and Drug Administration for the compatibility of the Nexel Total Elbow System with the Comprehensive Segmental Revision System. This 510(k) clearance marks the first submission by the Company to …read more.